Enlivex Therapeutics Ltd.
$1.35
-0.12 (-8.47%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- -30.8%
- 3 Months
- -88.9%
- YTD
- -87.2%
- 1 Year
- -91.7%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 89.6%
- Largest decline max drawdown, since Aug 2025
- -95.1%
- Risk-adjusted return Sharpe ratio, 1-year
- -2.26
Own ENLV?
See how ENLV contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.